AR059608A1 - Peptidos con capacidad anti - tumoral e inmunomoduladora - Google Patents

Peptidos con capacidad anti - tumoral e inmunomoduladora

Info

Publication number
AR059608A1
AR059608A1 ARP070100749A ARP070100749A AR059608A1 AR 059608 A1 AR059608 A1 AR 059608A1 AR P070100749 A ARP070100749 A AR P070100749A AR P070100749 A ARP070100749 A AR P070100749A AR 059608 A1 AR059608 A1 AR 059608A1
Authority
AR
Argentina
Prior art keywords
peptides
tumor
immunomodulatory
amino acid
capacity
Prior art date
Application number
ARP070100749A
Other languages
English (en)
Spanish (es)
Inventor
Nieto Gerardo Enrique Guillen
Vallespi Maribel Guerra
Madrazo Isis Del Carme Torrens
Perez Hilda Elisa Garay
Benitez Jose Fernando Reyes
Castro Boris Ernesto Acevedo
Gomez Raimundo Ubieta
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of AR059608A1 publication Critical patent/AR059608A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP070100749A 2006-02-24 2007-02-22 Peptidos con capacidad anti - tumoral e inmunomoduladora AR059608A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20060047A CU23582A1 (es) 2006-02-24 2006-02-24 Péptidos con capacidad anti-tumoral e inmunomoduladora

Publications (1)

Publication Number Publication Date
AR059608A1 true AR059608A1 (es) 2008-04-16

Family

ID=38123823

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100749A AR059608A1 (es) 2006-02-24 2007-02-22 Peptidos con capacidad anti - tumoral e inmunomoduladora

Country Status (16)

Country Link
US (1) US8283324B2 (enExample)
EP (1) EP1992638B1 (enExample)
JP (1) JP5069250B2 (enExample)
KR (1) KR101456205B1 (enExample)
CN (1) CN101426813B (enExample)
AR (1) AR059608A1 (enExample)
AT (1) ATE493434T1 (enExample)
AU (1) AU2007218671B2 (enExample)
BR (1) BRPI0708148B1 (enExample)
CA (1) CA2638828C (enExample)
CU (1) CU23582A1 (enExample)
ES (1) ES2358845T3 (enExample)
MX (1) MX2008010893A (enExample)
RU (1) RU2430109C2 (enExample)
WO (1) WO2007095867A1 (enExample)
ZA (1) ZA200807034B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23674A1 (es) * 2007-07-31 2011-05-27 Ct Ingenieria Genetica Biotech Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica
EP2108372A1 (en) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Novel antimicrobial peptides
US20120237535A1 (en) * 2009-09-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Therapeutic Compositions For The Treatment of HPV-Induced Diseases
CU23897B1 (es) * 2010-05-31 2013-05-31 Ct De Ingeniería Genética Y Biotecnología Péptido para la terapia del cáncer
CN103724412A (zh) * 2013-09-29 2014-04-16 中国科学院海洋研究所 中国明对虾抗脂多糖因子及其制备和应用
WO2024006746A1 (en) * 2022-06-29 2024-01-04 Cdres Pharma Llc Immunologically active polypeptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2146667A1 (en) 1993-08-18 1995-02-23 Adolf Hoess Lipopolysaccharide-binding and neutralizing peptides
CU22700A1 (es) 1997-09-29 2001-07-31 Ct Ingenieria Genetica Biotech Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso
WO2002038164A1 (en) 2000-11-08 2002-05-16 Lorus Therapeutics Inc. Combination preparation of a biological response modifier and an anticancer agent and uses thereof

Also Published As

Publication number Publication date
ZA200807034B (en) 2009-06-24
AU2007218671B2 (en) 2012-02-09
AU2007218671A1 (en) 2007-08-30
CA2638828A1 (en) 2007-08-30
CN101426813B (zh) 2012-04-04
RU2008137968A (ru) 2010-03-27
JP5069250B2 (ja) 2012-11-07
KR101456205B1 (ko) 2014-10-31
ATE493434T1 (de) 2011-01-15
US20090221508A1 (en) 2009-09-03
WO2007095867A1 (es) 2007-08-30
RU2430109C2 (ru) 2011-09-27
EP1992638A1 (en) 2008-11-19
CN101426813A (zh) 2009-05-06
CA2638828C (en) 2014-09-09
CU23582A1 (es) 2010-10-30
BRPI0708148A2 (pt) 2011-05-17
ES2358845T3 (es) 2011-05-16
JP2009527510A (ja) 2009-07-30
EP1992638B1 (en) 2010-12-29
US8283324B2 (en) 2012-10-09
KR20080106446A (ko) 2008-12-05
MX2008010893A (es) 2008-09-03
BRPI0708148B1 (pt) 2019-01-15

Similar Documents

Publication Publication Date Title
PH12020500308A1 (en) Preparation of therapeautic exosomes using membrane proteins
AR059608A1 (es) Peptidos con capacidad anti - tumoral e inmunomoduladora
PE20171442A1 (es) Peptidos y combinacion de peptidos novedosos para su uso en inmunoterapia contra diversos tumores
EA201891127A1 (ru) Нуклеиновые кислоты, кодирующие повторяющиеся аминокислотные последовательности с высоким содержанием пролиновых и аланиновых остатков, имеющие нуклеотидные последовательности с низкой повторяемостью
EA200971129A1 (ru) Циклические пептиды-антагонисты cxcr4
MX2009013682A (es) Enlazador de fmoc polimerico hidrolizable.
NZ737796A (en) Anti-tau antibodies and methods of use
EA201070812A1 (ru) Лечение и профилактика амилоидоза
PE20140004A1 (es) Combinaciones antitumorales que contienen anticuerpos que reconocen especificamente cd38 y bortezomib
EA201792245A1 (ru) Биоконъюгаты и их применения
CR20110221A (es) Terapia de combinación con péptidos epoxicetonas peptídicas
RU2012147589A (ru) Новые отдельные химические структурные единицы и способы доставки олигонуклеотидов
AR072032A1 (es) Tratamiento de enfermedades inflamatorias del intestino con beta defensinas de mamiferos
MX359201B (es) Polipeptidos que se unen al complemento humano 5 (c5).
BR112012029975A2 (pt) peptídeo como medicamento, em particular para o tratamento do câncer.
AR095386A1 (es) Péptidos de kntc2 y vacunas que los contienen
GB201118201D0 (en) Novel peptides
EA201101531A1 (ru) Способ лечения острого миелоидного лейкоза
CY1114618T1 (el) Βιολογικα δραστικα πεπτιδια που περιεχουν καρβοξυτελικη αργινινη
PE20230343A1 (es) Peptidos que estimulan respuestas inmunitarias antitumorales
UA114298C2 (uk) Пептид торк та вакцина, що його містить
EA201590601A1 (ru) Применение pedf-производных полипептидов для лечения остеоартрита
EP2552462A4 (en) CCN3 THERAPEUTIC PEPTIDES AND THEIR ANALOGS
MX2010010177A (es) Fragmentos de beta timosina mejorada.
FR3001729B1 (fr) Mutants du facteur x

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee